2016-2020 US Tumor Markers Diagnostic Testing Market: Supplier Shares by Test, and Market Segment Sales Forecasts
This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Table of ContentsBusiness Environment 1. Health Care Expenditures 2. Cost Consciousness 3. Industry Consolidation 4. Managed Care 5. Hospitals 6. Admissions 7. Length of Stay 8. Industry Diversification 9. Physician Demographics10. Population Aging a. Chronic Illness b. Disease Incidence c. Susceptibility to Iatrogenesis d. Multiple Illness Cases11. Laboratory RegulationsMarket Structure 1. Centralized Testing a. Hospitals b.commercial/Private Laboratories 2. Decentralized Testing a. Physician Offices/Group Practices b. Cancer Clinics c. Point-of-Care Testing d. Other Decentralized Testing LocationsMarket Size, Growth, and Major Suppliers Market SharesList of TablesTest Volume Forecasts by Market SegmentSales Forecasts by Market SegmentAFP Testing: Market Shares of Major SuppliersCA 15-3/27-29 Testing: Market Shares of Major SuppliersCA 19-9 Testing: Market Shares of Major SuppliersCEA Testing: Market Shares of Major SuppliersPSA Testing: Market Shares of Major SuppliersContains 40 pages and 7 tables
BUSINESS ENVIRONMENT
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
MARKET STRUCTURE
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Cancer Clinics
c. Point of Care Testing
d. Other Decentralized Testing Locations
MARKET SIZE GROWTH AND MAJOR SUPPLIERS’ MARKET SHARES
LIST OF TABLE
Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
AFP Testing: Market Shares of Major Suppliers
CA 15-3/27-29 Testing: Market Shares of Major Suppliers
CA 19-9 Testing: Market Shares of Major Suppliers
CEA Testing: Market Shares of Major Suppliers
PSA Testing: Market Shares of Major Suppliers
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
MARKET STRUCTURE
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Cancer Clinics
c. Point of Care Testing
d. Other Decentralized Testing Locations
MARKET SIZE GROWTH AND MAJOR SUPPLIERS’ MARKET SHARES
LIST OF TABLE
Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
AFP Testing: Market Shares of Major Suppliers
CA 15-3/27-29 Testing: Market Shares of Major Suppliers
CA 19-9 Testing: Market Shares of Major Suppliers
CEA Testing: Market Shares of Major Suppliers
PSA Testing: Market Shares of Major Suppliers
More Publications
2016-2020 U.K. Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 5,360.00
March 2016
1122 pages
2016-2020 U.K. Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies
US$ 5,440.00
March 2016
565 pages
2016-2020 U.S. Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies
US$ 7,840.00
March 2016
620 pages
